Histopathology—the microscopic study of tissue to diagnose disease—has long been confined to specialized hospital labs with in-house pathologists. But with advances in digital pathology and secure logistics, outsourcing these services is now both practical and precise. AsiaLabs bridges that gap, offering clinics and smaller labs access to expert histopathology diagnostics without the need for on-site infrastructure.
Reimagining diagnostic excellence through remote histopathology in Vietnam.
A New Era for Pathology
Histopathology has long been regarded as an in-house discipline — one that relies on microscopes, glass slides, and pathologists seated within the same physical lab. Yet in today’s connected world, this model limits access for smaller clinics and provincial hospitals.
AsiaLabs is transforming that reality. By combining modern automation, secure digital infrastructure, and expert diagnostic networks, the company has made remote histopathology not only possible but practical — bridging distance and ensuring that even small-volume clinics can deliver hospital-grade biopsy diagnostics.
The Challenge of Traditional Histopathology
For decades, the gold standard in tissue diagnosis has remained unchanged: specimens collected at clinics are processed, sectioned, stained, and reviewed under a microscope on-site.
However, this process demands significant capital investment in equipment, specialized staff, and high-volume throughput to be cost-effective.
For smaller or regional clinics, the cost of maintaining a histopathology unit can be prohibitive. The result? Patients must travel long distances for biopsies, or clinics outsource work overseas, creating delays in care.
AsiaLabs recognized the urgent need for a smarter, more accessible solution.
How the AsiaLabs Remote Histopathology Model Works
The AsiaLabs pipeline is designed around reliability, traceability, and speed — ensuring every specimen follows a validated, standardized workflow from pickup to reporting.
- Pickup and Transport
Clinics receive pre-labelled formalin containers, biopsy cassettes, and barcodes. AsiaLabs’ logistics team ensures same-day pickup, even for small-volume centers across six cities. - Processing and Staining
Upon arrival, tissue samples are embedded, sectioned, and H&E-stained using international-grade automation and strict quality protocols. Most cases are completed within 48 hours. - Slide Digitization and Secure Storage
Slides are scanned at 40x resolution using high-performance whole-slide scanners. Each digital file is securely stored and instantly accessible to AsiaLabs’ in-house or consulting pathologists. - Cloud-Based Diagnosis and Review
Pathologists—ASCP-certified and trained under both Vietnamese and international systems—review digital slides remotely through a peer-review platform, ensuring diagnostic accuracy and auditability. - Final Reporting and Delivery
Reports are delivered in both PDF and DICOM formats, ready for EMR integration. Each report includes annotated images for better clinical communication.
Bringing Pathology to Clinics Without Labs
AsiaLabs currently supports over 40 partner clinics, ranging from gynecology and ENT to dermatology and gastrointestinal practices.
For these partners, the benefits are tangible:
- Faster turnaround (typically 48 hours)
- Reduced operating cost without needing in-house pathologists
- Higher diagnostic consistency through standardized digital workflows
This model empowers smaller clinics to deliver sophisticated biopsy services previously limited to large hospitals. Patients gain convenience and confidence; doctors retain clinical control.
Ensuring Accuracy and Compliance
Digital pathology at AsiaLabs isn’t just convenient—it’s compliant with stringent diagnostic standards.
Each step of the process, from tissue handling to slide digitization, is validated to maintain morphology and staining quality. All cases can undergo secondary review by senior consultants within the same digital platform—ensuring transparency and accountability.
The Future of Remote Pathology
AsiaLabs’ remote histopathology pipeline reflects a broader global trend: the decentralization of diagnostics through technology. As AI-assisted analysis and remote peer review mature, even more specialized tests will move toward the digital model.
By pioneering this shift in Vietnam, AsiaLabs demonstrates that high-quality pathology can be both accessible and affordable—without compromising accuracy.
In short, outsourcing histopathology no longer means losing control. With the right backend partner, it means gaining capacity, consistency, and confidence.